Filing Flows › ICU Medical (ICUI) › R&D spending
ICU Medical (ICUI) R&D spending by quarter
ICU Medical's R&D spending was $21.8M in Q3 2026 (third quarter 2026), -4% from Q2 2026. Over the last 6 quarters it ranged from $21.3M (Q3 2025) to $23.3M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $21.8M | -4% | +2% |
| Q2 2026 | $22.7M | +7% | +4% |
| Q1 2026 | $21.3M | +0.1% | -9% |
| Q3 2025 | $21.3M | -3% | — |
| Q2 2025 | $21.9M | -6% | — |
| Q1 2025 | $23.3M | — | — |
Q3 2026 at a glance
ICU Medical, Q3 2026: revenue $560M (+4% year over year), operating margin 9.3%, net earnings $26.8M, operating cash flow $99.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is ICU Medical's R&D spending?
ICU Medical's R&D spending was $21.8M in Q3 2026 (third quarter 2026), -4% from Q2 2026.
How has ICU Medical's R&D spending changed?
Over the last 6 quarters it ranged from $21.3M (Q3 2025) to $23.3M (Q1 2025).